Published date: 2 October 2023
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Influenza vaccines - 33651660
Location of contract
E14 4PU
Value of contract
£1
Procurement reference
CF-1883000D0O000000rwimUAA
Published date
2 October 2023
Closing date
14 March 2022
Closing time
1pm
Contract start date
1 September 2023
Contract end date
31 August 2027
Contract type
Supply contract
Procedure type
Competitive dialogue (above threshold)
Tenders are invited from pre-qualified suppliers after discussion of requirements and potential solutions.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
Agreement for the reservation of manufacturing capacity and production and supply of influenza pandemic specific vaccine during a pandemic.
More information
Attachments
-
- APA contract 2023 Final Redacted.pdf
- APA contract 2023 Final Redacted
Additional text
-
The contract has the option to be extended for up to 6 years in fixed increments of 2 years at
a time (i.e. 4+2+2+2). The total contract term including any extensions will not exceed 10
years.
Information on the contract value has been withheld pursuant to regulation 50(6)(b) of the
Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate
commercial interests of the supplier.
The contract is for the benefit of the Authority & NHS bodies along with any other non-NHS
bodies which are necessary for the delivery of services or goods to NHS bodies, local
authorities, other government departments & their executive agencies or non-departmental
public bodies charged with the delivery of healthcare or health related services in the United
Kingdom, Crown Dependencies & British Overseas Territories including without limitation,
the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
The resulting products delivered against the contract may be made available to the UK
devolved administrations, Crown Dependencies & British Overseas Territories to undertake
their respective vaccination programmes.
Award information
Awarded date
30 August 2023
Contract start date
1 September 2023
Contract end date
31 August 2027
Total value of contract
£1
This contract was awarded to 1 supplier.
SEQIRUS UK LIMITED
Address
Point 29 Market Street SL6 8AA
Reference
None
Supplier is SME?
No
About the buyer
Contact name
Laura Hale
Address
10 South Colonnade
London
E14 4PU
GB
Share this notice
Closing: 14 March 2022, 1pm